Beyond COVID-19, brain fog has been been observed in many other medical conditions
In that same study, 29% of people taking metformin daily lost greater than or equal to 5% or more of their initial body weight by the end of the first year, compared with 13% of people in the placebo group
C.BieniasJ
7583% achieved 15% 26% of participants on 12 mg achieved 30% weight reduction Cardiometabolic Parameters Improvements in blood pressure, HbA1c, fasting glucose, insulin, LDL-cholesterol 72% of patients with prediabetes achieved normoglycemia Safety Most common adverse events: gastrointestinal (nausea, diarrhea, constipation) , dose-dependent, predominantly mild to moderate Heart rate: slight increase up to week 24, then decrease No severe hypoglycemia, medullary carcinoma, or C-cell hyperplasia Conclusions Retatrutide induced significant, dose-dependent weight reduction of up to 24.2% over 48 weeks
The problem is that normal is not healthy in first-world countries today